OSTEOPOROSIS

This study looks at whether group exercise classes designed for people with osteoporosis who have recently had a fracture are safe and practical. Researchers will enroll 100 participants to attend classes and track how many sign up, stick with the program, and attend sessions. Th…

This study looks at whether semaglutide, a common diabetes drug, affects bone density and fracture risk in people with type 2 diabetes. About 150 adults aged 50-75 with low bone mass or a recent fracture will take either semaglutide plus metformin or metformin alone for 12 months…

This study compares two bone-strengthening drugs (ibandronate and zoledronic acid) given after stopping denosumab in postmenopausal women with osteoporosis. The goal is to see which drug better maintains bone density and prevents bone loss. The trial involves 52 women aged 50-85 …

This study tests whether denosumab, a bone-strengthening drug, can help prevent fractures in people with type 2 diabetes who are at high risk for broken bones. About 358 adults aged 45 and older with long-standing diabetes or related complications will receive denosumab plus stan…

This study tests a medical food called SBD111, made of probiotics and fiber, designed to help manage bone loss after menopause. Healthy adults aged 35 and older will take the food once or twice daily for 28 days. Researchers will check if the new dosing schedule keeps enough good…

This study explores whether a natural waste product called AGE, which builds up in the body over time, can predict how well osteoporosis medications work. Researchers will measure AGE levels in 240 postmenopausal women starting bone-strengthening drugs and track their bone densit…

This study is testing an AI voice assistant named Dora that calls patients after a bone fracture to ask about their health. The goal is to see if Dora can safely and accurately collect information, like risk factors and medication use, compared to a human clinician. About 217 pat…

This study looks back at people who already received a special treatment (AGN1 LOEP) for weak bones in the hip. Researchers will check if any new hip fractures or side effects happened after the procedure. About 305 people from European hospitals will be contacted by phone to sha…

This study will review medical records from 8,000 adults with osteoporosis who had a first fragility fracture. Researchers want to measure how many months pass before patients start anti-fracture medication, and whether delays lead to more fractures. The goal is to understand the…